The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Nov. 07, 2019
Applicant:
Vivace Therapeutics, Inc., San Mateo, CA (US);
Inventors:
Andrei W. Konradi, Burlingame, CA (US);
Tracy Tzu-Ling Tang Lin, Redwood City, CA (US);
Assignee:
VIVACE THERAPEUTICS, INC., San Mateo, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07C 233/65 (2006.01); C07C 233/69 (2006.01); C07C 235/66 (2006.01); C07C 237/48 (2006.01); C07C 271/16 (2006.01); C07C 307/06 (2006.01); C07C 311/16 (2006.01); C07C 311/51 (2006.01); C07C 317/32 (2006.01); C07D 205/04 (2006.01); C07D 213/40 (2006.01); C07D 213/61 (2006.01); C07D 213/73 (2006.01); C07D 213/74 (2006.01); C07D 213/84 (2006.01); C07D 215/48 (2006.01); C07D 215/54 (2006.01); C07D 217/18 (2006.01); C07D 231/56 (2006.01); C07D 233/64 (2006.01); C07D 235/06 (2006.01); C07D 239/26 (2006.01); C07D 239/28 (2006.01); C07D 241/12 (2006.01); C07D 241/44 (2006.01); C07D 257/04 (2006.01); C07D 261/12 (2006.01); C07D 263/56 (2006.01); C07D 271/12 (2006.01); C07D 277/82 (2006.01); C07D 285/08 (2006.01); C07D 295/13 (2006.01); C07D 305/06 (2006.01); C07D 307/22 (2006.01); C07D 333/58 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07C 233/65 (2013.01); C07C 233/69 (2013.01); C07C 235/66 (2013.01); C07C 237/48 (2013.01); C07C 271/16 (2013.01); C07C 307/06 (2013.01); C07C 311/16 (2013.01); C07C 311/51 (2013.01); C07C 317/32 (2013.01); C07D 205/04 (2013.01); C07D 213/40 (2013.01); C07D 213/61 (2013.01); C07D 213/73 (2013.01); C07D 213/74 (2013.01); C07D 213/84 (2013.01); C07D 215/48 (2013.01); C07D 215/54 (2013.01); C07D 217/18 (2013.01); C07D 231/56 (2013.01); C07D 233/64 (2013.01); C07D 235/06 (2013.01); C07D 239/26 (2013.01); C07D 239/28 (2013.01); C07D 241/12 (2013.01); C07D 241/44 (2013.01); C07D 257/04 (2013.01); C07D 261/12 (2013.01); C07D 263/56 (2013.01); C07D 271/12 (2013.01); C07D 277/82 (2013.01); C07D 285/08 (2013.01); C07D 295/13 (2013.01); C07D 305/06 (2013.01); C07D 307/22 (2013.01); C07D 333/58 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01);
Abstract
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.